Victory Square Technologies Reports 2024 Achievements and Outlines 2025 Strategic Vision
Victory Square Technologies reported significant achievements for 2024 and outlined its 2025 strategic vision. The company achieved $10.7M in Q3 net income and reported an unaudited Net Asset Value of $127.5M as of January 28, 2025. Their subsidiary Hydreight Technologies ranked #56 on the 2024 Deloitte Technology Fast 500, achieved profitability, and launched a $10M Health Accelerator program.
The company's VSDHOne platform now powers healthcare brands across all 50 U.S. states, offering telehealth and compliance solutions. Key developments include Insu Therapeutics' work on oral insulin delivery technology, Stardust Solar's expansion into Houston with a $1.2M raise, and EdgeTI's advancement in quantum computing applications.
The company's portfolio has grown from $4M in 2017 to approximately $127M today, with investments totaling $13M across 25 companies selected from over 1,000 evaluated.
Victory Square Technologies ha riportato risultati significativi per il 2024 e ha delineato la sua visione strategica per il 2025. L'azienda ha raggiunto $10,7M di utile netto nel Q3 e ha registrato un Valore Netto degli Attivi non verificato di $127,5M al 28 gennaio 2025. La loro sussidiaria Hydreight Technologies si è classificata al #56 nella lista 2024 Deloitte Technology Fast 500, ha raggiunto la redditività e ha lanciato un programma di Salute Accelerata da $10M.
La piattaforma VSDHOne dell'azienda ora supporta marchi di assistenza sanitaria in tutti i 50 stati degli Stati Uniti, offrendo soluzioni di telemedicina e conformità. Sviluppi chiave includono il lavoro di Insu Therapeutics sulla tecnologia di consegna di insulina orale, l'espansione di Stardust Solar a Houston con una raccolta da $1,2M e i progressi di EdgeTI nelle applicazioni di calcolo quantistico.
Il portafoglio dell'azienda è cresciuto da $4M nel 2017 a circa $127M oggi, con investimenti totali di $13M in 25 aziende selezionate da oltre 1.000 valutate.
Victory Square Technologies informó logros significativos para 2024 y delineó su visión estratégica para 2025. La compañía logró $10.7M en ingresos netos en el tercer trimestre y reportó un Valor Neto de Activos no auditado de $127.5M al 28 de enero de 2025. Su subsidiaria Hydreight Technologies ocupó el puesto #56 en la lista 2024 de Deloitte Technology Fast 500, alcanzó la rentabilidad y lanzó un programa de Acelerador de Salud de $10M.
La plataforma VSDHOne de la compañía ahora impulsa marcas de atención médica en los 50 estados de EE. UU., ofreciendo soluciones de telemedicina y cumplimiento. Los desarrollos clave incluyen el trabajo de Insu Therapeutics en tecnología de entrega de insulina oral, la expansión de Stardust Solar a Houston con una recaudación de $1.2M y los avances de EdgeTI en aplicaciones de computación cuántica.
El portafolio de la compañía ha crecido de $4M en 2017 a aproximadamente $127M hoy, con inversiones totales de $13M en 25 empresas seleccionadas de más de 1,000 evaluadas.
Victory Square Technologies는 2024년에 대한 중요한 성과를 보고하고 2025년 전략적 비전을 설명했습니다. 이 회사는 3분기 순이익 $10.7M을 달성했으며 2025년 1월 28일 기준으로 감사되지 않은 순자산가치가 $127.5M이라고 보고했습니다. 자회사 Hydreight Technologies는 2024년 Deloitte Technology Fast 500에서 56위를 차지하고 수익을 달성했으며, $10M의 건강 가속기 프로그램을 출시했습니다.
회사의 VSDHOne 플랫폼은 현재 미국 50개 주 전역에서 의료 브랜드에 전력을 공급하며, 원격 의료 및 준수 솔루션을 제공합니다. 주요 개발 사항으로는 Insu Therapeutics의 경구 인슐린 전달 기술 개발, Stardust Solar가 휴스턴에 $1.2M을 모금하여 확장하는 것, EdgeTI의 양자 컴퓨팅 응용 프로그램 발전 등이 있습니다.
회사의 포트폴리오는 2017년 $4M에서 오늘 대략 $127M으로 성장했으며, 1,000개 이상의 평가된 기업 중에서 선택된 25개 기업에 총 $13M의 투자를 기록했습니다.
Victory Square Technologies a rapporté des réalisations significatives pour 2024 et a esquissé sa vision stratégique pour 2025. L'entreprise a réalisé 10,7 millions de dollars de bénéfice net au T3 et a déclaré une valeur nette d'actifs non vérifiée de 127,5 millions de dollars au 28 janvier 2025. Sa filiale Hydreight Technologies a été classée #56 dans le classement 2024 Deloitte Technology Fast 500, a atteint la rentabilité et a lancé un programme d'accélérateur de santé de 10 millions de dollars.
La plateforme VSDHOne de l'entreprise alimente désormais des marques de santé dans les 50 États américains, offrant des solutions de télémédecine et de conformité. Parmi les développements clés, on trouve le travail d'Insu Therapeutics sur la technologie de délivrance d'insuline orale, l'expansion de Stardust Solar à Houston avec une levée de fonds de 1,2 million de dollars, et l'avancement d'EdgeTI dans les applications de calcul quantique.
Le portefeuille de l'entreprise est passé de 4 millions de dollars en 2017 à environ 127 millions de dollars aujourd'hui, avec des investissements totalisant 13 millions de dollars dans 25 entreprises sélectionnées parmi plus de 1 000 évaluées.
Victory Square Technologies berichtete über bedeutende Erfolge für 2024 und skizzierte seine strategische Vision für 2025. Das Unternehmen erzielte 10,7 Millionen Dollar Nettogewinn im 3. Quartal und meldete zum 28. Januar 2025 einen nicht geprüften Nettovermögenswert von 127,5 Millionen Dollar. Ihre Tochtergesellschaft Hydreight Technologies belegte den 56. Platz im Deloitte Technology Fast 500 für 2024, erzielte Rentabilität und startete ein Gesundheitsbeschleunigungsprogramm im Wert von 10 Millionen Dollar.
Die VSDHOne Plattform des Unternehmens unterstützt jetzt Gesundheitsmarken in allen 50 Bundesstaaten der USA und bietet Telemedizin- und Compliance-Lösungen an. Zu den Hauptentwicklungen gehören die Arbeit von Insu Therapeutics an der Technologie zur oralen Insulindelivierung, die Expansion von Stardust Solar nach Houston mit einer Kapitalerhöhung von 1,2 Millionen Dollar und die Fortschritte von EdgeTI bei Anwendungen der Quantencomputing.
Das Portfolio des Unternehmens ist von 4 Millionen Dollar im Jahr 2017 auf etwa 127 Millionen Dollar heute gewachsen, mit insgesamt 13 Millionen Dollar an Investitionen in 25 Unternehmen, die aus über 1.000 bewerteten ausgewählt wurden.
- Q3 2024 net income of $10.7M with EPS of $0.11
- Hydreight Technologies achieved profitability in 2024
- Portfolio value growth from $4M in 2017 to $127M in 2025
- Hydreight's network expansion to 2,500+ nurses and 100+ doctors across all 50 states
- Successful $1.2M fundraise for Stardust Solar
- None.
- Significant Net Income Growth: Victory Square achieved
$10.7M in Q3 net income - Unaudited Net Asset Value (NAV): Estimated at
$127,524,464 * as of January 28, 2025 (see Use of Non-GAAP Financial Measures). - Digital Health Expansion: The VSDHOne platform powers healthcare brands across all 50 U.S. states, offering telehealth, compliance solutions, and direct-to-consumer scalability.
- Hydreight Technologies' Milestones: Hydreight ranked #56 on the 2024 Deloitte Technology Fast 500™, achieved profitability in 2024, and launched a
$10M Health Accelerator to foster the next generation of digital health entrepreneurs. - Diabetes Care Advancements: Insu Therapeutics is developing oral delivery technology for insulin and peptide-based drugs, targeting the
$118B global diabetes market. - Sustainability in Action: Stardust Solar expands into Houston, partners with Tesla, and raises
$1.2M to support renewable energy initiatives. - Frontier Technologies: EdgeTI advances quantum computing applications, while XR Immersive integrates continuous glucose monitoring (CGM) technology for enhanced diabetes management.
- 2025 Vision: Strategic focus on scaling digital health solutions, accelerating portfolio growth, and enhancing shareholder value.
Vancouver, British Columbia--(Newsfile Corp. - January 30, 2025) - Victory Square Technologies Inc. (CSE: VST) (OTCQB: VSQTF) (FSE: 6F6) ("Victory Square" or the "Company") is a venture builder that provides investors with access to a diversified portfolio of 25+ high-growth companies in digital health, renewable energy, artificial intelligence, and more-all within a single stock. The company identifies and scales transformative technologies, driving long-term shareholder value. The Company is pleased to provide its latest Corporate Update. The report highlights significant milestones achieved in 2024 and strategic priorities aimed at driving innovation and shareholder value in 2025.
To Our Valued Shareholders,
As we enter 2025, Victory Square Technologies (VST) remains focused on advancing digital health and driving meaningful innovation. The healthcare sector is undergoing significant transformation, influenced by rising costs, an aging population, and rapid technological advancements.
Digital health presents a major opportunity to enhance accessibility, efficiency, and patient outcomes. As Marc Andreessen noted, "Healthcare is undergoing a software revolution." VST is committed to leveraging this shift to develop scalable, patient-centric solutions that create long-term value for both the healthcare industry and our shareholders.
Hydreight Technologies: Scaling Direct-to-Consumer Healthcare
Hydreight Technologies (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) continues to demonstrate strong growth and industry impact:
- Deloitte Technology Fast 500™ Recognition: Ranked #56, with a three-year revenue compound annual growth rate (CAGR) of
54% . (Source: Deloitte Fast 500 Report) - Expanding Provider Network: Over 2,500 nurses, 100 doctors, and a 503B pharmacy network covering all 50 U.S. states.
- Achieved Profitability in 2024: A milestone reflecting operational efficiency, market leadership, and a scalable business model. (Source: Company Press Release)
$10M Health Accelerator Program: In partnership with Victory Square, Hydreight is investing in early-stage digital health companies using the VSDHOne platform to enable scalable growth. (Source: Company Press Release)- Expanded Telehealth Offerings: New services include GLP-1 medications, genetic testing, and hormone replacement therapy, addressing a broad range of patient needs.
- Launch of VSDHOne: Strengthening digital health infrastructure and supporting business growth across multiple healthcare sectors.
Strategic Partnership: Hydreight and The DRIPBaR
Hydreight Technologies has partnered with The DRIPBaR to launch 'DRIPBaR Direct,' a nationwide direct-to-consumer healthcare initiative powered by the VSDHOne platform. This collaboration enables The DRIPBaR to offer seamless telehealth consultations and physician-prescribed wellness treatments across the country, leveraging a compliant infrastructure and competitive pricing models comparable to established brands like HIMS. (Source: Company Press Release)
Portfolio Expansion Beyond Digital Health
Insu Therapeutics:
- University of British Columbia (UBC) spinoff developing oral drug delivery technologies for diabetes care.
- Targeting the
$118B global diabetes drug market, addressing a growing patient population of over 783 million individuals. - Advancing regulatory approvals with FDA and EMA for innovative peptide-based treatments.
Stardust Solar (TSXV: SUN):
- Expanded U.S. operations with a Houston franchise launch. (Source: Company Announcement)
- Partnered with Tesla to accelerate renewable energy adoption. (Source: Tesla Collaboration Agreement)
- Raised
$1.2M in an oversubscribed private placement. (Source: Company Press Release)
Edge Total Intelligence (TSXV: CTRL):
- Developing quantum computing applications and digital twin technology. (Source: Company Update)
- Secured C
$5M in private placement financing for product development. (Source: Financial Press Release)
XR Immersive Technologies (CSE: VRAI):
- Acquired InsulinQ's CGM technology to enhance diabetes management solutions. (Source: Acquisition Announcement)
Financial Strength and Growth Outlook
- Q3 2024 Financial Results: Net income of
$10,661,274 and earnings per share of$0.11 , demonstrating strong execution and growth. - Unaudited Net Asset Value (NAV): Estimated at
$127,524,464 * as of January 28, 2025 (see Use of Non-GAAP Financial Measures).
"At Victory Square, we measure success through key performance indicators that reflect our growth: Cash Invested, Net Asset Value (NAV), Return on Invested Cash, Share Price/Market Cap vs. Index Benchmark, and Operating Costs as a % of NAV. Since 2017, we have evaluated over 1,000 companies, selecting 25 for investment. To date, we have invested
Strategic Focus: Digital Health & Expansion
Victory Square's continued emphasis on digital health is aligned with market demand for scalable, patient-centric healthcare solutions. Through Hydreight and VSDHOne, Victory Square is:
- Enabling Businesses to Scale: Providing a compliant telehealth infrastructure for nationwide expansion.
- Diversifying Healthcare Offerings: Supporting businesses in offering GLP-1 medications, lab testing, ED treatments, hair loss solutions, NAD therapy, genetic testing, and hormone replacement therapy.
- Accelerating Portfolio Growth: Strengthening partnerships and acquisitions to enhance revenue and market reach.
Looking Ahead: 2025 Growth Strategy
In 2025, Victory Square is focused on:
- Expanding Digital Health Infrastructure: Strengthening VSDHOne as a leading telehealth platform.
- Fueling Portfolio Growth: Supporting companies with capital and resources to scale efficiently.
- Enhancing Shareholder Value: Driving NAV growth and generating sustainable long-term returns.
"Victory Square is committed to advancing technology and healthcare solutions that improve accessibility and patient outcomes. Our 2024 results demonstrate our strategic execution, and we are focused on continuing this momentum into 2025 and beyond."
- Shafin Diamond Tejani, Chairman and CEO, Victory Square Technologies
Join Us in 2025
Victory Square invites investors, partners, and stakeholders to be part of its journey in shaping the future of digital health and technology-driven innovation.
For further information about Victory Square, please contact:
Investor Relations Contact - Abbey Vogt
Email: ir@victorysquare.com
Telephone: 604 283-9166
Peter Smyrniotis - Director
Telephone: 604 283-9166
*Use of Non-GAAP Financial Measures:
This release contains references to NAV which is a non-GAAP financial measure. NAV is calculated as the value of total assets. The term NAV does not have any standardized meaning according to GAAP and therefore may not be comparable to similar measures presented by other companies. There is no comparable GAAP financial measure presented in Victory Square Technologies Inc. consolidated financial statements and thus no applicable quantitative reconciliation for such non-GAAP financial measure. The Company believes that the measure provides information useful to its shareholders in understanding the Company's performance, and may assist in the evaluation of the Company's business relative to that of its peers. This data is furnished to provide additional information and does not have any standardized meaning prescribed by GAAP. Accordingly, it should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP, and is not necessarily indicative of other metrics presented in accordance with GAAP. Existing NAV of the Company is not necessarily predictive of the Company's future performance or the NAV of the Company as at any future date.
About Victory Square Technologies Inc.
Victory Square is a Venture Builder that offers investors a liquid way to invest in early-stage technology companies without requiring accredited investor status or long-term commitments typically associated with venture funds.
- A diverse portfolio of 25+ innovative companies from around the world (founders hail from Ireland, Sri Lanka, Bulgaria, Australia, India, Brazil, the Middle East, and North America)
- Sectors include: Digital Health, Artificial Intelligence (AI), Machine Learning (ML), Web3, Virtual & Augmented Reality (VR/AR), Gaming, Climate Tech
- Owner-operated (approx.
15% Management Ownership)
Business Model:
Victory Square's business model focuses on buying, building, and investing in early-stage tech companies. We dedicate up to 48 months with these companies to help them grow and become ready to spin-off or stand on their own. Some unique elements of our approach include:
- Unparalleled Access: Through our internal incubator and international network, we connect with over 250 founders, investors, tech accelerators, and venture capital firms from more than 60 countries.
- Active Involvement: Our management team and advisors provide financial, operational, and strategic support to scale companies globally-from incubation to monetization.
- Reinvestment Strategy: We drive value by monetizing investments and reinvesting the gains into new innovations, ensuring that our business remains self-sustaining.
Victory Square Technologies is publicly traded, headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6), and OTCQX (VSQTF).
For more information, visit www.victorysquare.com.
ABOUT THE CANADIAN SECURITIES EXCHANGE (CSE)
The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets.
FORWARD-LOOKING INFORMATION
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the outlook of the business of Victory Square and its portfolio companies, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects and opportunities of Victory Square and its related subsidiaries and portfolio companies, including those items listed under the heading "Net Asset Value ("NAV") Update", "Notable Portfolio Highlights" and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as "believes", "expects", "to be", "anticipates", "estimates", "intends", "plans", "continues", "project", "potential", "possible", "contemplate", "seek", "goal", "objectives", "outlook" or similar expressions, or may employ such future or conditional verbs as "may", "might", "will", "could", "should" or "would", or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Although Victory Square believes that the expectations reflected in forward-looking statements in this press release are reasonable, such forward-looking statements has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Victory Square's control, including, but not limited to, the risk factors discussed in the continuous disclosure materials of the Victory Square which are available under the Victory Square's profile on SEDAR at www.sedar.com. The forward-looking statements contained in this press release are expressly qualified by this cautionary statement and are made as of the date hereof. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/238906
FAQ
What was Victory Square Technologies (VSQTF) Q3 2024 net income?
What is Victory Square Technologies' (VSQTF) current Net Asset Value?
How many companies has VSQTF invested in since 2017?
What ranking did Hydreight Technologies achieve in the 2024 Deloitte Technology Fast 500?
How much did Victory Square's Stardust Solar subsidiary raise in their recent funding?
